The study seeks to determine the accuracy of using anatomic and physiologic information measurable by computed tomography features of stenosis, plaque, fractional flow reserve-CT and to compare this measure to stress testing for the detection of myocardial ischemia against the gold standard of cardiac catheterization with fractional flow reserve. The hypothesis of this proposal is that integrating anatomic plaque features with physiologic fractional flow reserve-CT will optimize identification of coronary lesions that are ischemia-causing by computed tomography .
The CREDENCE trial will be a prospective multicenter cross-sectional study of 618 individuals (n=309 \[derivation cohort\]; n=309 \[validation cohort\]) who will undergo stress test, computed tomography, cardiac catheterization and fractional flow reserve. For the purposes of the study, either stress test or computed tomography will have been performed for clinical purposes, with the other test being performed as part of trial procedure. Study analyses will focus on the diagnostic performance of the information derived by stress test versus computed tomography against an invasive gold standard of cardiac catheterization and fractional flow reserve for an endpoint of vessel territory-specific ischemia. In keeping with prior studies, vessel territories will be comprised of the left anterior descending artery (and diagonal branches), the left circumflex artery (and obtuse marginal branches) and the right coronary artery (and posterolateral branch and posterior descending artery). To date, the relative performance of traditional stress imaging testing compared to the entirety of information proffered by CT has not been assessed compared to an unbiased gold standard. The study proposed herein will directly address this unmet need.
Study Type
OBSERVATIONAL
Enrollment
618
Heart Center Research, LLC
Huntsville, Alabama, United States
Mobile Cardiology Associates
Mobile, Alabama, United States
Kaiser Permanente Hospital
San Jose, California, United States
Oconee Heart and Vascular Center at St Mary's Hospital
Athens, Georgia, United States
St. Luke's Lipid and Diabetes Research Center
Kansas City, Missouri, United States
Renown Heart and Vascular
Reno, Nevada, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Houston Methodist Hospital
Houston, Texas, United States
Cardiac Center of Texas
McKinney, Texas, United States
Multicare HS Institute for Research & Innovation
Tacoma, Washington, United States
...and 8 more locations
Diagnostic accuracy of vessel territory-specific ischemia of an integrated stenosis-APC-FFRCT measure by CT
The primary endpoint is the diagnostic accuracy of an integrated stenosis-APC-FFRCT metric by CT, as compared to perfusion or perfusion-MBF stress imaging testing for vessel territory-specific ischemia as determined by FFR (gold standard).
Time frame: 48-60 months
Individual comparisons of APCs or FFRCT to MPI vessel-specific perfusion deficits or reduced MBF.
To compare the accuracy of the individual components of APCs or FFRCT to MPI vessel-specific perfusion deficits or reduced MBF against ischemia by FFR.
Time frame: 48-60 months
Post-PCI FFR prediction by FFRCT "virtual stenting"
To determine the accuracy of FFRCT "virtual stenting" to post-PCI FFR value of \>0.80 and determine the correlation between the FFRCT "virtual stenting" to post-PCI FFR.
Time frame: 48-60 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.